|
|
Administrative Supplement - Role of microbiota-TLR7/8 Interaction in systemic lupus erythematosus |
| 3R01AI138511-02S1 |
VASU, CHENTHAMARAKSHAN |
NIA |
2020 |
|
|
Isoform-specific roles of AMPK in synaptic failure and memory deficit in Alzheimers Disease |
| 5R01AG055581-04 |
MA, TAO |
NIA |
2020 |
|
|
Role of Ataxin-1 in BACE1 Expression and Alzheimers Disease |
| 5R01AG056775-03 |
SUH, JAEHONG |
NIA |
2020 |
|
|
ApoE Genotype-Directed Drug Repositioning and Combination Therapy for Alzheimers Disease |
| 5R01AG057683-04 |
HUANG, YADONG |
NIA |
2020 |
|
|
Systematic elucidation of endosomal trafficking as a therapeutic opportunity in AD using CRISPR-based functional genomics |
| 5R01AG062359-03 |
KAMPMANN, MARTIN |
NIA |
2020 |
|
|
Regulation of Neuronal Clearance Pathways via Nuclear Calcium Signaling in Alzheimers Disease |
| 5R01AG062475-02 |
DOBROWOLSKI, RADOSLAW |
NIA |
2020 |
|
|
Statistical and computational methods for integrative analysis of Alzheimers Disease genetics |
| 5R01AG066206-02 |
HE, ZIHUAI |
NIA |
2020 |
|
|
Utilizing beige fat to improve muscle function after rotator cuff repair |
| 5R01AR072669-03 |
FEELEY, BRIAN |
NIA |
2020 |
|
|
Pyroglutamate-modified Amyloid-B protein as a marker for future cognitive decline in preclinical Alzheimers disease |
| 5R03AG063235-02 |
AYYAPPAN PILLAI, JAGAN |
NIA |
2020 |
|
|
Gene co-expression underlying the connectomic alterations in Alzheimers disease |
| 5R21AG066135-02 |
YAN, JINGWEN |
NIA |
2020 |
